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Abstract
Introduction:  The  aim  of  this  study  was  to  determine  the  incidence  of  neck  bleeding,  requiring
or not  surgical  intervention,  after  carotid  endarterectomy  (CE)  and  to  identify  its  predictive
parameters  and  its  inﬂuence  in  stroke,  myocardial  infarction  (MI)  and  mortality.
Methods:  This  was  a  retrospective  review  of  200  CEs  carried  out  in  194  patients  between  2010
and 2014  in  our  institution.  The  endpoints  were:  postoperative  major  cervical  bleeding  MB  (that
required reintervention)  and  global  cervical  bleeding  GB  (registered  neck  bleeding)  as  also  its
major post  reintervention  complications.  Patient  demographics,  antiplatelet  and  anticoagulant
therapy  (pre,  intra  and  postoperative),  anesthetic  data,  surgical  technique,  and  perioperative
management  data  were  collected.  Univariate  analysis  with  Pearson  chi-Squared  or  Fisher  Test
was applied  for  categorical  variables  and  t-test  for  continuous  variables.
Results: Neck  bleeding  after  CE  occurred  in  25  cases  (12%),  requiring  reoperation  in  8  cases
(4.0%). Univariate  analysis  (Pearson  chi-squared  test)  showed  signiﬁcance  (p  <  0.05)  for  global
hematoma in  which  concerns  clopidogrel  use  until  surgery  (p  =  0.04),  elevated  mean  arterial
pressure  during  hospitalar  stay  (p  =  0.006).  For  major  hematoma  it  has  signiﬁcance  previous
dual antiplatelet  therapy  (p  =  0.039),  patch  use  compared  to  other  techniques  (p  =  0.017),  and
neurological  repercurssion  after  clamping  (p  =  0.03).  Individual  analysis  of  surgical  technique
did not  show  signiﬁcant  value  for  major  or  global  hematoma.  There  were  to  2  deaths,  one
related to  reeintervention,  2  strokes  and  one  MI  nonprocedure  associated.
Conclusions:  Carotid  hematoma  is  a  devastating  and  relatively  common  complication  in  our
institution  although  the  incidence  of  major  hematoma  is  reduced.  The  main  factors  associated
with reeintervention  were  previous  double  anti-platelet  therapy,  non-patch  surgical  techniques
and patient  neurological  instability  (shunt  use),  probably  associated  with  less  accurate  hemosta-
sis. Global  bleeding  is  related  to  the  use  of  clopidogrel  24  h  before,  and  as  post-operative  factors
poor tensional  control  (high)
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PALAVRAS-CHAVE
Fatores  preditivos;
Hematoma
do  pescoc¸o;
Endarterectomia
carotídea;
Complicac¸ões
Factores  preditores  de  hematoma  após  endarterectomia  carotidea:  revisão  de  5  anos
Resumo
Introduc¸ão:  O  objetivo  deste  estudo  consiste  na  determinac¸ão  da  incidência  de  hematoma
carotídeo após  endarterectomia  carotídea  (EC),  identiﬁcando  os  fatores  preditivos  do  mesmo
e a  sua  inﬂuência  em  complicac¸ões  major,  nomeadamente  AVC,  EAM  e  mortalidade.
Material  e  métodos:  Estudo  retrospetivo  de  200  EC  em  194  doentes,  entre  2010-2014,  na
nossa instituic¸ão.  Os  endpoints  primários  foram  a  incidência  de  hematoma  carotídeo  major
(requerendo  intervenc¸ão)  e  hematoma  carotídeo  global  registados  e  as  complicac¸ões  major
pós reintervenc¸ão.  Foram  colhidos  os  dados  demográﬁcos,  os  dados  de  antiagregac¸ão  e
hipocoagulac¸ão pré,  intraoperatórios  e  pós-operatórios  imediato,  técnica  anestésica  e  cirúr-
gica e  detalhes  da  vigilância  pós-operatória.  Foi  efetuada  análise  univariada  com  o  teste
qui-quadrado  de  Pearson  ou  Fisher  para  variáveis  categóricas,  teste  t  para  contínuas,  calculando
os odds  ratio  (OR)  para  a  inﬂuência  destes  fatores  relativamente  ao  grupo  sem  hematoma.
Resultados:  A  incidência  de  hematoma  carotídeo  registado  foi  de  25  casos  (12%),  e  de  8  casos
(4%) de  hematoma  major  requerendo  intervenc¸ão.  A  análise  univariada  (teste  qui-quadrado
de Pearson)  mostrou  signiﬁcância  (p  <  0,05)  para  o  hematoma  global  no  que  diz  respeito  à
utilizac¸ão de  clopidogrel  até  à  cirurgia  (p  =  0,04),  pressão  arterial  média  elevada  durante
a estadia  hospitalar  (p  =  0,006).  Para  o  hematoma  major  é  signiﬁcativo  a  dupla  terapêutica
antiagregante  (p  =  0,039),  uso  de  patch  em  comparac¸ão  com  outras  técnicas  (p  =  0,017)
e repercussão  neurológica  após  o  clampagem  (p  =  0,03).  A  análise  individual  das  técnicas
cirúrgicas  não  foi  signiﬁcativa  para  o  hematoma  major.  Ocorreram  2  mortes,  uma  relacionada
à reintervenc¸ão,  2  AVC  e  um  EAM  não  associado  à  cirurgia.
Conclusões:  O  hematoma  de  carotídeo  é  uma  complicac¸ão  devastadora  e  relativamente  comum
na nossa  instituic¸ão,  embora  a  incidência  de  hematoma  major  seja  reduzida.  Os  principais
fatores associados  à  reintervenc¸ão  foram:  terapêutica  dupla  antiagregante,  não  uso  de  patch
(técnicas cirúrgicas)  e  instabilidade  neurológica  do  paciente  (uso  shunt),  provavelmente  asso-
ciado a  hemostase  menos  precisa.  A  hemorragia  global  está  relacionada  com  a  utilizac¸ão  do
clopidogrel 24  horas  antes  da  cirurgia,  e  como  fatores  pós-operatórios  o  fraco  controlo  tensional
(alto).
© 2015  Sociedade  Portuguesa  de  Angiologia  e  Cirurgia  Vascular.  Publicado  por  Elsevier  España,
S.L.U. Este  é  um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
r
a
e
t
r
M
T
o
b
i
c
D
C
needed  after  carotid  endarterectomy  which  was  inherentlyIntroduction
Carotid  hematoma  is  a  well-known  complication  of  vas-
cular  surgeon  with  major  consequences  in  morbidity  and
mortality  depending  on  the  surgeon’s  quick  actuation.  The
incidence  of  carotid  hematoma  in  the  literature  varies
between  1.2  and  12%1--8 which  reﬂects  both  the  hematoma
requiring  intervention  and  uncomplicated  postoperative
hemorrhage.  Several  factors  have  been  identiﬁed  as  predic-
tors  of  neck  bleeding  in  previous  studies.6,9,10 These  factors
can  be  arranged  in  preoperative,  intraoperative  or  postop-
erative.  The  ﬁrst  group  includes  patient  morbidity  factors,
antiplatelet  and  anticoagulation  therapy,  creatinine  level
and  platelets.  Intraoperative  factors  refer  to  the  operator,
neurological  alterations  during  surgery,  shunt  use,  surgical
technique,  protamine  use,  mean  arterial  pressure.  Finally
postoperative  factors,  such  as  blood  pressure  control  and
postoperative  coagulation,  are  also  associated  with  carotid
endarterectomy  bleeding.The  primary  endpoint  of  this  study  was  to  determine,
over  a  period  of  ﬁve  years  (2010--2014)  in  200  CEs,
the  incidence  of  complicated  hemorrhage  (CH)  needing
a
beintervention  and  global  hemorrhage  (GH)  and  its  associ-
tion  with  those  previous  mentioned  factors.  A  secondary
nd-point  was  to  determine  the  incidence  of  periopera-
ive  mortality  and  morbidity  (stroke  and  MI)  hemorrhage
elated.
aterial and methods
his  was  a  single-center,  retrospective,  non-randomized,
bservational  study  of  all  CEs  performed  in  our  institution,
etween  January  2010  and  December  2014.  Demographics,
ntra-operative  and  perioperative  data  (until  15  days)  were
ollected  from  our  retrospective  database.
eﬁnitions
omplicated  hemorrhage  (CH),  if  surgical  exploration  wasssociated  with  the  need  for  intubation.
Global  hemorrhage  (GH),  CH  plus  uncomplicated  neck
leeding  deﬁned  as  hematoma  at  surgical  site  without
1t
r
o
a
(
o
r
c
P
P
T
c
a
t
-
t
t
s
a
s
W
s
l
1
A
T
b
p
t
i
l
a
b
I
v
C
S
T
a
(
d
r
s
d
t
p
r
i
o
a
i
U
C
o
G
t
c
u
F
C
s
a
s
I
s
S
S
u
t
ﬁ
t
e
d
i
R
F
f
p
(
r
(
c
s
(
d
C
O
C
t4  
ransfusional  support,  airway  obstruction,  requirement  of
eintubation  or  reoperation  and  blood  drainage  <500  ml
verall.
Mean  Arterial  Blood  Pressure  (MABP);  parameter  evalu-
ted  in  this  study  and  calculated  as:  (systolic  blood  pressure
mmHg)  +  2  ×  dyastolic  blood  pressure)/3.
For  intraoperative  blood  pressure,  the  value  is  a  mean
f  the  3  highest  values,  excluding  those  associated  to  arte-
ial  clamping.  For  postoperative  MABP  it’s  a  mean  of  values
alculated  during  hospital  stay.
reoperative  protocol
atients  are  globally  admitted  the  day  before  surgery.
hey  underwent  preoperative  electrocardiogram,  blood-
ount  with  platelets,  biochemistry  including  renal  function
nd  coagulation  study.  A  vast  majority  of  patients  were
reated  with  single  antiplatelet  therapy  (acetylsalicylic  acid
- ASA  100  mg/24  h  or  clopidogrel  75  mg/24  h).  In  our  insti-
ution,  most  of  those  patients  taking  ASA  do  not  stop
herapy  but  clopidogrel  is  usually  stopped  5--7  days  before
urgery,  according  to  surgeon  choice.  Hipocoagulation  ther-
py  with  oral  anticoagulants  (e.g.  Varﬁne,  Sintrom)  is  always
topped  5--7  days  before  and  replaced  by  Low  Molecular
eight  Heparine  (LMWH)  which  is  given  the  night  before
urgery.  Locoregional  anesthesia  requires  a  normal  coagu-
ation  study,  if  hemostasis  is  altered,  it  may  be  necessary  a
0-mg  vitamin  K  dose.
nesthetic  technique
he  choice  of  the  anesthetic  technique  is  decided  by
oth  surgeon  and  anesthetist,  and  based  also  on  patient
reference,  clinical  and  behavioral  expected  characteris-
ics.  In  our  hospital  most  of  times  locoregional  anesthesia
s  used  with  exceptions  of  patient  preference,  bad  col-
aboration,  non-reversible  coagulation  alterations.  Invasive
rterial  blood  pressure  by  arterial  access  is  always  made  plus
ispectral  index  control  (BIS  Vista:  Aspect  Medical  Systems,
nc.)  last  one  during  general  anesthesia.
Antimicrobial  prophylaxis  is  made  with  2-g  intra-
enous  (IV)  cefazolin  and  400  mg  Teicoplanin  or  500  mg  IV
yproﬂoxacin  if  there  is  an  allergy  to  beta-lactams.
urgical  technique  and  perioperative  management
he  surgical  technique  depends  mainly  on  surgeon  choice
nd  includes:  eversion  thromboendarterectomy,  patch
venous  or  synthetic)  closure  thromboendarterectomy  and
irect  closure,  the  last  one  usually  required  by  patient  neu-
ological  instability.Systemic  heparinization  with  5000  IU  dose  of  heparin
odium  is  used,  excluding  renal  dysfunction,  with  function
ependent  reduction.  There  were  no  reversions  with  pro-
amine.
If  general  anesthesia  is  applied,  back  ﬂow  arterial
ressures  are  measured,  when  below  40  mmHg  or  a  50%
eduction  of  mean  arterial  pressure,  carotid--carotid  shunt
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s  used.  In  locoregional  anesthesia,  shunt  use  is  dependent
n  neurological  status  alterations  monitored  before,  during
nd  after  clamping.
The  patches  used  were  very  rarely  saphenous  patches
n  2  cases,  and  Dacron  (Dacron  patch  Hemashield  Finesse
ltra-thinPlatinum  Knitted  Cardiovascular  Patch,  Maquet
ardiovascular,  LLC,  Wayne,  NJ),  or  expanded  polytetraﬂu-
roethylene  --  PTFE  (Gore  Cardiovascular  Patch  Acuseal,  WL
ore  &  Associates,  Inc.,  Flagstaff,  AZ).  It  was  used  rou-
inelyin  all  patients  a  14  or  16  French  suction  drain  system
onnected  to  a  vacuum  system,  and  dismissed  24  h  after  an
ncomplicated  surgery.
ollow-up
linical  follow-up  is  in  Intermedial,  Post-Anesthetic  or  Inten-
ive  Unit  Care  for  12--24  h  with  antiplatelet  therapy  (ASA)
nd  40  mg  SC  LMWH  are  usually  given  at  night.  When
topped,  clopidogrel  is  only  given  1  week  after  surgery.
n  uncomplicated  surgeries,  patients  go  home  48  h  after
urgery.
tatistical  analysis
PSS  for  Windows  (version  20.0;  SPSS  Inc.,  Chicago,  IL)  was
sed  for  statistical  analysis.  The  variables  associated  with
he  presence  of  bleeding  and  major  bleeding  were  identi-
ed  by  univariate  analysis  for  categorical  variables,  using
he  Pearson  chi-squared  test  or  Fisher  test  if  2  cells  have
xpected  count  less  than  5,  Student’s  t-test  for  continuous
ata  and  odds  ratio  calculation  (OR)  with  95%  conﬁdence
ntervals  (CIs).
esults
rom  January  2010  to  December  2014,  200  EC  were  per-
ormed  in  194  patients  and  6  (3%)  were  bilateral  during  this
eriod.  The  average  age  of  the  patients  was  69.3  ±  8.6  years
range:  42--87  years);  74%  were  men  and  26%  women.  Patient
isk  factors  are  mainly  hypertension  (94%)  and  dyslipidemia
91%)  and  most  of  them  where  symptomatic  (64%).  Most
ommon  surgical  technique  is  thromboendarterectomy  with
ynthetic  patch  closure  (64%)  under  locoregional  anesthesia
94%).  Demographic,  clinical,  operative  and  post-operative
ata  are  summarized  in  Table  1.
ervical  hematoma
verall  postoperative  cervical  hematoma  occurred  in  25
EAs  of  200  CE  (12.5%).  Seventeen  were  treated  conserva-
ively,  and  8  cases  were  severe  hematomas  which  required
eeintervention.  Symptoms  associated  with  the  presence
f  severe  hematoma  were:  cervical  edema  in  8  (100%),
ysfagia  4  (50%),  dyspneia  2  (25%).  However  about  half  of
hem  had  only  cervical  edema,  without  other  symptoms.
even  in  a  total  of  8  patients  were  reeinterventionated  24  h
fter  CE.  Intraoperatively  the  vast  majority  5  (63%)  of  the
ases  were  diffuse  bleedings  without  an  identiﬁable  cause,
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1  was  a  patch  associated  and  1  a  facial  venous  branch  bad
ligation.
Factors predisposing to bleeding
Preoperative  factors
In  the  univariate  analysis  (Table  2),  none  of  demographic
characteristics  of  patients  were  associated  with  postop-
erative  bleeding,  however  coronary  disease  has  an  almost
signiﬁcant  (p  =  0.06)  association  with  major  bleeding.  When
analyzing  and  comparing  anti-platelet  regimens  in  coronary
disease  patients  they  are  more  often  under  dual  therapy
(ASA  +  clopidogrel),  26%  versus  9%  with  p  =  0.003,  a  signiﬁ-
cant  difference  which  can  justify  this  positive  association.
No  other  anti-platelet  therapy  schemes  were  signiﬁcantly
associated  with  bleeding  (Tables  3  and  4).
Antiplatelet and anticoagulation therapy
For  major  bleeding,  global  dual  antiplatelet  therapy  was  sig-
niﬁcantly  associated  with  reeintervention  (p  = 0.03,  Pearson
Chi-squared  test)  and  OR  =  4.6,  but  no  positive  association
was  made  if  clopidogrel  was  not  stopped  before,  which  only
happened  in  6  patients  (3%).  Also  in  GH,  it  seems  to  be  a  ten-
dency  for  bleeding  with  this  medical  approach  as  shown  by
very  close  signiﬁcances  (p  =  0.06,  Pearson  Chi  squared  test)
and  OR  =  2.6.  Clopidogrel  previous  therapy  until  CE  had  a sig-
niﬁcant  effect  on  GH  (p  =  0.04,  Fisher  test),  but  when  it  was
stopped  no  signiﬁcant  neck  bleeding  was  identiﬁed.  LMWH
in  previous  anticoagulated  patients  was  not  associated  with
bleeding.
Intraoperative  factors
In  what  concerns  surgical  technique  (Table  5)  it  was  com-
pared  each  single  technique  was  compared  with  the  others;
there  were  no  statistically  signiﬁcant  differences  for  global
hematoma.  For  major  hematoma  synthetic  patch  use  is  asso-
ciated  with  less  events  than  the  others  techniques;  only
2  major  hematoma  in  134  patch  technique  use  (1.5%)  and
6  events  for  the  other  surgical  techniques  (66  episodes),
9.1%,  p  =  0.017.  This  is  also  true  for  neurological  intraop-
erative  deﬁcit  after  clamping  (p  =  0.03)  and  OR  =  6,  more
bleeding  associated  with  neurological  instability  during
surgery.
Postoperative  factors
In  what  concerns  patients  perioperative  follow-up,  coag-
ulation  study  and  MABP  during  hospital  stay  was  studied,
Table  3.  The  only  factor  that  has  a  signiﬁcant  p  value
is  Blood  Pressure  and  Global  Bleeding  (p  =  0.006),  patients
with  poor  BP  control  (high)  had  more  tendency  to  bleed.
Postoperative  coagulation  study  was  evaluated  using  APTT
cut-off  of  40  (greater  than  40  abnormal),  but  no  sig-
niﬁcant  results  are  associated  with  postoperative  APTT
changes.
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nﬂuence  on  major  complications
erioperative  mortality  at  30  days  was  2/200  (1%)  one
f  them  hematoma  related,  and  a  total  of  2  strokes  in
on-reeinterventionated  patients.  There  was  also  one
I  non-hematoma  associated.
iscussion
his  study  showed  a  global  bleeding  rate  of  12.5%,  with
ajor  bleeding  representing  just  4%  (8  patients)  which
equired  reeintervention.  This  result  is  comparable  to  other
ublished  studies  in  literature  1--12%1,2,6,8,9 and  reaches  up
5%  when  less  severe  bleeding  (radiological  and  clinical
riteria)  is  considered.10 It  seems  to  be  reasonable  to  men-
ion  those  cases  because  there  is  an  inevitable  operator
ubjectivity  to  deﬁne  indication  for  intervention,  which  can
ffect  results.
There  is  not  a Universal  criteria  for  surgical  interven-
ion  in  our  institution,  so  this  individual  decision  is  made  on
n  individual  basis,  however  there  are  some  clinical  crite-
ia  (transfusional  support,  airway  obstruction,  requirement
f  reintubation  or  reoperation  and  blood  drainage  <500  ml
verall)  that  indicate  a  surgical  intervention.
Symptoms  associated  to  hematoma  were  not  always
traightforward,  about  50%  of  patients  had  just  neck  tume-
action,  so  a  high  clinical  suspicion  and  sometimes  surgeon
ggressive  attitude  was  mandatory.  It  is  absolutely  crucial  to
erform  an  early  intubation,  to  avoid  more  severe  morbidity
ssociated  to  tracheotomy.  Our  death  was  associated  with
 failed  attempt  to  intubate,  and  a  consequent  fatal  airway
bstruction.
Regarding  factors  affecting  bleeding,  as  in  previous
tudies,6,9 demographic  factors  did  not  show  a  signiﬁcant
ssociation  with  bleeding  rates,  however  this  study  found
n  almost  signiﬁcant  association  with  coronary  disease  and
ajor  bleeding  probably  related  with  dual  anti-platelet
herapy  which  was  signiﬁcantly  most  common  in  coronary
iseased  patients.
Anti-platelet  treatment  associated  with  major  bleeding
as  ASA  +  clopidogrel  even  when  stopped  5--7  days  before,
hich  suggests  a  residual  effect  from  this  medication  as
emonstrated  in  2001  by  Weber  in  a  single  cell  analy-
is  that  shown  an  irreversible  mode  of  action  in  humans.
lso,  for  general  bleeding,  clopidogrel  was  signiﬁcantly
ssociated  (p  =  0.04,  OR  =  3.9)  with  hematoma  if  it  was
ontinued  until  procedure,  similar  to  other  previous  pub-
ished  studies.6,9,11--14 Dual  antiplatelet  therapy  was  even
ssociated  previously  with  all-cause  mortality  after  carotid
evascularization  for  asymptomatic  carotid  disease,15 with
pparent  small  beneﬁts  in  reducing  embolic  new  episodes
n  symptomatic  patients.  None  of  our  8  patients  with  major
leeding  keep  clopidogrel  so  it  is  not  possible  to  evaluate
ts  action  in  this  group.  Low  Molecular  Weight  Heparine  (in
ipocoagulated  patients)  did  not  affect  bleeding,  proba-
ly  owing  to  more  rigorous  pre  and  postoperative  clinical
urveillance.
Intraoperative  factors  associated  with  major  bleeding
here  surgical  technique,  with  eversion  plus  direct  closure
nd  venous  patch  use  (2  cases),  had  a  signiﬁcant  p  value
0.017)  of  bleeding  comparing  to  patch  use.  This  is  prob-
bly  justiﬁed  by  surgical  technique  associated  bias  (direct
1 A.  Ferreira  et  al.
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Table  1  Patient  demographic,  clinical,  intraoperative  and
postoperative  data.
Variables  No  (%),  mean
range  or
mean  ±  SD
Patients,  total  194
Procedures  200
Age,  years  69.3  (42--87)
Male  144  (74%)
Female  25  (26%)
Risk  factors  (for  procedure)
Hypertension  188  (94%)
Smoking
Current  smoker  46  (23%)
Past  smoker  43  (22%)
Dyslipidemia  182  (91%)
Coronary  disease  42  (21%)
Peripheral  arterial  obstructive  disease
(PAOD)
59  (30%)
Symptoms
Symptomatic  patient  127  (64%)
Stroke  82  (41%)
Transient  ischemic  attack  (TIA)  including
amaurosis  fugax
45  (22%)
Antithrombotic  medication
172  (86%)
Clopidogrel  alone  21  (11%)
Until  CEA  3  (1.5%)
Stopped  before  CEA  (5--7  days)  18  (9%)
Clopidogrel  plus  ASA 25  (12%)
Until  CEA 6  (3.0%)
Stopped  dual  regimen  before  CEA  (5--7  days) 2  (1%)
Clopidogrel  stop  (5--7  days)  before  CEA 18  (9%)
Ticlopidine 2  (1%)
Until  CEA 2  (1%)
Stopped  before  CEA  (5--7  days) 0
ASA alone 129  (65%)
Until  CEA  126  (62%)
Stopped  before  CEA  (5--7  days)  6  (3.0%)
No antithrombotic  medication  28  (14.0%)
Mean  platelet  count  (×109/  L)  208  (56--379)
Intraoperative  variables
Local  anesthesia  188  (94%)
General  anesthesia  12  (6%)
Conversion  to  general  anesthesia  3  (1.6%)
Shunt  placement  7  (4%)
Surgical  technique
Eversion  37  (19%)
CEA with  prosthetic  patch  134  (64%)6  
losure  in  neurological  instable  patients)  which  leads  to  a
ess  accurate  hemostasis,  as  shown  by  signiﬁcant  neurologi-
al  repercussion  after  clamping  (p  =  0.03,  OR  =  6.3)  in  major
leeding.  Direct  closure  was  used  as  a  mean  of  diminishing
perative  time,  in  neurological  instable  patients  and  alter-
ative  to  shunt  use,  according  to  surgeons’  criteria.  However
hen  analyzing  independently  eversion  and  direct  closure,
omparing  to  the  others  techniques,  p  value  was  not  signif-
cant  for  each  individual  technique.
None  of  those  intraoperative  previous  factors  had  a  sig-
iﬁcant  impact  in  global  bleeding,  however  they  were  close
o  signiﬁcance.
Finally,  postoperative  factors  namely  high  arterial  blood
ressure,  had  a  very  strong  effect  (p  =  0.006)  in  global  bleed-
ng,  similar  to  other  previous  studies9 justifying  established
nti-hypertensive  protocols  at  the  Unit  Care.
onclusions
ostoperative  severe  bleeding  in  our  institution,  although
are,  is  a  considerable  complication,  comparable  to  other
xperienced  centers.  There  is  no  signiﬁcant  morbidity  or
ortality  associated  to  reeintervention  which  suggests  an
ggressive  and  immediate  actuation.  Previous  clopidogrel
se  is  associated  with  major  and  global  bleeding,  espe-
ially  if  it  is  used  24  h  before  surgery.  Intraoperative  factor
s  neurological  instability  is  associated  with  poor  hemosta-
is  and  consequent  major  bleeding.  Surgical  technique  like
version  or  direct  closure  are  associated  with  more  major
ematoma  which  can  be  associated  with  less  accurate
emostasis  in  direct  closure  (bias),  however  they  do  not
ave  signiﬁcance  when  individually  compared.  Postopera-
ive  factors  such  as  a  high  BP  are  associated  with  global
leeding.
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nnexes.
ables  1--6.
CEA with  venous  patch 2  (1.0%)
Direct  closure 25  (12%)
Neurological  repercussion  after  clamping  in
local  anesthesia
18  (9.6%)
Maximal  mean  intra-operative  BP  110  mmHg
Postoperative  variables
MABP  during  hospitalar  stay  97  mmHg  (±15  mmHg)
APTT  (mean)  59.6
APTT  >  50  35  (18%)
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Table  2  Risk  of  neck  bleeding  in  general  and  neck  bleeding  requiring  re-exploration  related  to  clinical  demographic  data
(preoperative)  --  univariate  analysis.
Variable Neck  bleeding
General  (N  =  25)  Requiring  re-exploration  (N  =  8)
OR/Mean  difference  (95%  CI) p  OR/Mean  difference  (95%  CI) p
Male  2.69  (0.77--9.4)  0.11  0.74  (0.68--0.80)  0.20
Hypertension  0.93  (0.89--0.97)  0.37  0.94  (0.90--0.97)  0.60
Smoking 1.07  (0.399--2.85)  0.92  0  0.13
Dyslipidemia  2.58  (0.328--20.3)  0.71  0.68  (0.08--0.68)  0.54
Coronary disease 1.22  (0.454--3.28) 0.69 4.05  (0.97--16.9)  0.06*
PAOD 2.08  (0.88--4.90) 0.09 2.49  (0.60--10.3) 0.24
Platelet count −7.38  (−51.9:−37.2) 0.18 −7.38  (−51.9:  7.20) 0.5
Age (years)  0.167  (−5.95:6.28)  0.19  0.56  (−6.48:7.50)  0.96
Symptoms (symptomatic  vs  asymptomatic)  1.63  (0.249--1.35)  0.20  0.56  (0.14--2.3)  0.47
* p value very close to signiﬁcance.
Table  3  Differences  between  antithrombotic  regimen  in  coronary  and  noncoronary  patients.
Anti-thrombotic  medication  and  coronary  disease
Coronary  disease  Noncoronary  disease  p  value
N =  42  (21%)  N  =  138  (79%)
N (%)  N  (%)
ASA  +  Clopidogrel  11  (26%)  14  (8.9%)  0.003
Clopidogrel  5  (12%)  16  (10%)  0.8
ASA 23  (55%)  106  (67%)  0.14
Table  4  Risk  of  neck  bleeding  in  general  and  neck  bleeding  requiring  re-exploration  related  to  antithrombotic/hipocoagulation
medication  --  univariate  analysis.
Neck  bleeding
General  (N  =  25)  Requiring  re-exploration  (N  =  8)
Clopidogrel  alone
Until CE  3.84  (0.57--19.5)  0.043** 0.96  (0.93--0.99)  1.0
Stopped 5--7  days
before
0.48  (0.317--0.221)  0.32  1.14  (1.0--1.3)  0.28
Clopidogrel  +  ASA  0.097** Fisher  0.060** Fisher
Global (including
clopidogrel  stopped
5--7  days  before)
2.6  (0.92--7.3)  0.063** Pearson  4.64  (1.0--20.8)  0.029* Pearson
Clopidogrel +  ASA
(stopped
clopidogrel  5--7
days  before)
1.8  (0.4--7.3)  0.59  1.17  (0.98--1.39)  1.0
ASA until  CEA  1.65  (0.54--5.1)  0.96  1.15  (0.98--1.35)  0.59
Stopped 5--7  days
before
1.2  (0.14--11.3)  1.0  4.7  (0.47--46)  0.25
LMWH (all  until  CEA)  2.03  (0.62--6.7)  0.27  0.96  (0.93--0.99)  1.0
* Signiﬁcant p value.
** p value very close to signiﬁcance.
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Table  5  Risk  of  neck  bleeding  in  general  and  neck  bleeding  requiring  re-exploration  related  to  intraoperative  data  --  univariate
analysis.
Variable  Neck  bleeding
General  (N  =  25) Requiring  re-exploration  (N  =  8)
OR/mean
difference  (CI  95%)
p  OR/mean
difference  (CI  95%)
p
Anesthesia  0.70  (0.14--3.38) 0.65 0.94  (0.90--0.97) 1.0
Local/General
Shunt 1.00  (0.14--10.2)  0.61  4.40  (0.4--41.5)  0.25
Surgical  technique
Direct closure  0.39  (0.14--1.1)  0.07* 0.41  (0.079--2.2)  0.28
CEA with  synthetic  patch  0.56  (0.24--1.32)  0.18  6.6  (1.3--33)  0.017*
Eversion  technique  0.81  (0.26--2.5)  0.71  2.75  (0.68--12.1)  0.16
Neurological repercussion  after  clamping 2.5  (0.982--9.64) 0.060** 6.28  (1.36--28.9) 0.034*
Intraop  MABP  −4.33  (−11.5:7.85)  0.14  −16.17  (−28.1:−4.24)  0.40
Intraop: intraoperative.
* Signiﬁcant p value.
** p value very close to signiﬁcance.
Table  6  Risk  of  neck  bleeding  in  general  and  neck  bleeding  requiring  re-exploration  related  to  postoperative  data  --  univariate
analysis.
Postoperative
variables
General  (N  =  25) Requiring  re-exploration  (N  =  8)
OR  (CI  95%)/mean
difference  (CI  95%)
p  OR  (CI  95%)/mean
difference  (CI  95%)
p
MABP  during
hospitalar  stay
41.4  (12.3:70.5)  0.006* −6.53  (−53.9:43.9)  0.97
Post operative
APTT  (normal  vs
abnormal)
1.70  (0.589--4.91)  0.97  1.10  (0.196--6.43)  1.0
* Signiﬁcant p value.
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